CMRX - CHIMERIX INC

QQQ $ 611.70 $ 5.09 (0.84 %)

DIA $ 467.20 $ 1.51 (0.32 %)

SPY $ 672.21 $ 3.96 (0.59 %)

TLT $ 91.38 $ -0.63 (-0.68 %)

GLD $ 378.90 $ 1.51 (0.4 %)

Previous Close

$ 8.54

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.75 - $ 8.55

Volume

755,560

Average Volume

Market Cap

801.08M

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-21-2025	12-31-2024	10-K
2	11-07-2024	09-30-2024	10-Q
3	08-13-2024	06-30-2024	10-Q
4	05-01-2024	03-31-2024	10-Q
5	02-29-2024	12-31-2023	10-K
6	11-02-2023	09-30-2023	10-Q
7	08-03-2023	06-30-2023	10-Q
8	05-04-2023	03-31-2023	10-Q
9	03-02-2023	12-31-2022	10-K
10	11-03-2022	09-30-2022	10-Q
11	08-08-2022	06-30-2022	10-Q
12	05-16-2022	03-31-2022	10-Q
13	03-01-2022	12-31-2021	10-K
14	11-04-2021	09-30-2021	10-Q
15	08-05-2021	06-30-2021	10-Q
16	05-06-2021	03-31-2021	10-Q
17	02-25-2021	12-31-2020	10-K
18	11-05-2020	09-30-2020	10-Q
19	08-10-2020	06-30-2020	10-Q
20	05-07-2020	03-31-2020	10-Q
21	02-25-2020	12-31-2019	10-K
22	11-05-2019	09-30-2019	10-Q
23	08-08-2019	06-30-2019	10-Q
24	05-09-2019	03-31-2019	10-Q
25	03-05-2019	12-31-2018	10-K
26	11-08-2018	09-30-2018	10-Q
27	08-08-2018	06-30-2018	10-Q
28	05-07-2018	03-31-2018	10-Q
29	03-01-2018	12-31-2017	10-K
30	11-08-2017	09-30-2017	10-Q
31	08-07-2017	06-30-2017	10-Q
32	05-09-2017	03-31-2017	10-Q
33	03-02-2017	12-31-2016	10-K
34	11-07-2016	09-30-2016	10-Q
35	08-08-2016	06-30-2016	10-Q
36	05-09-2016	03-31-2016	10-Q
37	02-29-2016	12-31-2015	10-K
38	11-05-2015	09-30-2015	10-Q
39	08-06-2015	06-30-2015	10-Q
40	05-11-2015	03-31-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Top 3 Health Care Stocks That May Crash In Q2
04/07/2025 15:23:04

Chimerix Q4 2024 GAAP EPS $(0.25) Beats $(...
03/21/2025 10:04:57

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3...

This MongoDB Analyst Is No Longer Bullish;...
03/06/2025 14:39:00

Jones Trading Downgrades Chimerix to Hold,...
03/06/2025 11:27:42

Jones Trading analyst Soumit Roy downgrades Chimerix (NASDAQ:CMRX) from Buy to Hold and announces $8.55 price target.

Jefferies Downgrades Chimerix to Hold, Low...
03/05/2025 21:46:11

Jefferies analyst Maury Raycroft downgrades Chimerix (NASDAQ:CMRX) from Buy to Hold and lowers the price target from $10 to ...

Demystifying Chimerix: Insights From 4 Ana...
03/05/2025 19:00:28

HC Wainwright & Co. Downgrades Chimerix to...
03/05/2025 16:49:51

HC Wainwright & Co. analyst Edward White downgrades Chimerix (NASDAQ:CMRX) from Buy to Neutral and lowers the price targ...

jazz-pharma-to-buy-chimerix-for-935-million-strengthening-rare-cancer-pipeline

Jazz Pharma To Buy Chimerix For $935 Milli...
03/05/2025 13:41:43

Jazz Pharmaceuticals will add dordaviprone, a potential treatment for a rare brain tumor, to its growing oncology pipeline.

Trading Halt: Halt status updated at 7:25:...
03/05/2025 12:25:04

Jazz Pharmaceuticals To Acquire Chimerix F...
03/05/2025 12:04:47

Trading Halt: Halted at 6:55:00 a.m. ET - ...
03/05/2025 11:55:04

HC Wainwright & Co. Reiterates Buy on Chim...
02/18/2025 18:04:14

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

Chimerix Secures FDA Priority Review For D...
02/18/2025 12:33:03

Potential First Approval for Patients with Recurrent H3 K27M-mutant Diffuse GliomaPDUFA Target Action Date of August 18, 2025No...

"New Case Of Mpox Detected In The UK After...
01/27/2025 17:50:29

https://www.manchestereveningnews.co.uk/news/health/new-case-mpox-detected-uk-30876004 A new case of Mpox has been confirmed in...

A Glimpse Into The Expert Outlook On Chime...
12/30/2024 18:00:12

HC Wainwright & Co. Reiterates Buy on Chim...
12/30/2024 15:35:17

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

Chimerix Confirms That It Has Submitted Ne...
12/30/2024 12:10:57

Chimerix Seeks FDA Approval for New Drug T...
12/30/2024 12:01:28

Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and exte...

HC Wainwright & Co. Reiterates Buy on Chim...
12/11/2024 11:30:19

HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
12/10/2024 21:05:50